Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against <i>Trypanosoma cruzi</i>
Chagas disease (CD) still represents a serious public health problem in Latin America, even after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) are considered inadequate, especially because of undesirable side effects and low efficacy in the chronic stages o...
Main Authors: | Leonardo S. Lara, Guilherme C. Lechuga, Caroline dos S. Moreira, Thaís B. Santos, Vitor F. Ferreira, David R. da Rocha, Mirian C. S. Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/2/423 |
Similar Items
-
New Amino Naphthoquinone Derivatives as Anti-<i>Trypanosoma cruzi</i> Agents Targeting Trypanothione Reductase
by: Christian Espinosa-Bustos, et al.
Published: (2022-05-01) -
Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against <i>Trypanosoma cruzi</i>
by: Lorraine Martins Rocha Orlando, et al.
Published: (2021-11-01) -
Evaluation of some organic compounds on bloodstream forms of Trypanosoma cruzi
by: João S. Silva, et al.
Published: (1992-09-01) -
Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against <i>Trypanosoma cruzi</i>: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease
by: Leonardo da Silva Lara, et al.
Published: (2022-05-01) -
The Trypanocidal Activity of Naphthoquinones: A Review
by: Solange Lisboa de Castro, et al.
Published: (2009-11-01)